Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1930 1
1934 6
1935 2
1936 6
1946 1
1950 1
1951 1
1953 1
1954 1
1955 1
1956 1
1957 1
1958 2
1959 6
1961 1
1962 1
1963 1
1964 5
1965 9
1966 3
1967 2
1968 1
1969 3
1970 4
1972 1
1973 5
1974 2
1975 2
1976 7
1977 5
1978 9
1979 6
1980 3
1981 7
1982 11
1983 14
1984 19
1985 29
1986 26
1987 35
1988 38
1989 28
1990 36
1991 31
1992 49
1993 37
1994 43
1995 28
1996 45
1997 50
1998 49
1999 56
2000 69
2001 85
2002 76
2003 120
2004 130
2005 153
2006 203
2007 237
2008 293
2009 314
2010 440
2011 445
2012 569
2013 669
2014 713
2015 827
2016 838
2017 964
2018 1089
2019 1247
2020 1486
2021 1766
2022 1860
2023 1878
2024 1553
2025 7

Text availability

Article attribute

Article type

Publication date

Search Results

16,802 results

Results by year

Filters applied: . Clear all
Page 1
N6 -Methyladenosine Reader Protein YT521-B Homology Domain-Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic Genes.
Zhou B, Liu C, Xu L, Yuan Y, Zhao J, Zhao W, Chen Y, Qiu J, Meng M, Zheng Y, Wang D, Gao X, Li X, Zhao Q, Wei X, Wu D, Zhang H, Hu C, Zhuo X, Zheng M, Wang H, Lu Y, Ma X. Zhou B, et al. Among authors: hu c. Hepatology. 2021 Jan;73(1):91-103. doi: 10.1002/hep.31220. Epub 2020 Oct 25. Hepatology. 2021. PMID: 32150756
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial.
Qin S, Li J, Wang L, Xu J, Cheng Y, Bai Y, Li W, Xu N, Lin LZ, Wu Q, Li Y, Yang J, Pan H, Ouyang X, Qiu W, Wu K, Xiong J, Dai G, Liang H, Hu C, Zhang J, Tao M, Yao Q, Wang J, Chen J, Eggleton SP, Liu T. Qin S, et al. Among authors: hu c. J Clin Oncol. 2018 Oct 20;36(30):3031-3039. doi: 10.1200/JCO.2018.78.3183. Epub 2018 Sep 10. J Clin Oncol. 2018. PMID: 30199311 Free PMC article. Clinical Trial.
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
Wang SL, Fang H, Song YW, Wang WH, Hu C, Liu YP, Jin J, Liu XF, Yu ZH, Ren H, Li N, Lu NN, Tang Y, Tang Y, Qi SN, Sun GY, Peng R, Li S, Chen B, Yang Y, Li YX. Wang SL, et al. Among authors: hu c. Lancet Oncol. 2019 Mar;20(3):352-360. doi: 10.1016/S1470-2045(18)30813-1. Epub 2019 Jan 30. Lancet Oncol. 2019. PMID: 30711522 Clinical Trial.
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, Kong Y, Ren L, Wei Q, Mei H, Hu C, Tao C, Yang R, Wang J, Yu Y, Guo Y, Wu X, Xu Z, Zeng L, Xiong N, Chen L, Wang J, Man N, Liu Y, Xu H, Deng E, Zhang X, Li C, Wang C, Su S, Zhang L, Wang J, Wu Y, Liu Z. Li L, et al. Among authors: hu c. JAMA. 2020 Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044. JAMA. 2020. PMID: 32492084 Free PMC article. Clinical Trial.
Erythrocyte-inspired delivery systems.
Hu CM, Fang RH, Zhang L. Hu CM, et al. Adv Healthc Mater. 2012 Sep;1(5):537-47. doi: 10.1002/adhm.201200138. Epub 2012 Aug 1. Adv Healthc Mater. 2012. PMID: 23184788 Review.
The biological functions of microcystins.
Wei N, Hu C, Dittmann E, Song L, Gan N. Wei N, et al. Among authors: hu c. Water Res. 2024 Sep 15;262:122119. doi: 10.1016/j.watres.2024.122119. Epub 2024 Jul 18. Water Res. 2024. PMID: 39059200 Review.
Immunometabolism: a new dimension in immunotherapy resistance.
Xiao C, Xiong W, Xu Y, Zou J, Zeng Y, Liu J, Peng Y, Hu C, Wu F. Xiao C, et al. Among authors: hu c. Front Med. 2023 Aug;17(4):585-616. doi: 10.1007/s11684-023-1012-z. Epub 2023 Sep 19. Front Med. 2023. PMID: 37725232 Review.
16,802 results
You have reached the last available page of results. Please see the User Guide for more information.